细菌性肺炎机械通气患者镇静实践模式与短期结局:全国队列研究
该日本全国性队列研究纳入2018年4月至2023年3月因细菌性肺炎需机械通气的成人ICU患者3302例,分为联合镇静组(1135例)、丙泊酚为主组(1067例)和右美托咪定为主组(1100例),采用倾向评分匹配权重法调整混杂因素。主要复合结局为院内死亡和出院时功能下降。联合镇静与丙泊酚为主镇静相比,复合结局风险无显著降低(26.3% vs 30.0%;RD -3.7%;95%CI -8.0至0.7);但与右美托咪定为主镇静相比,复合结局风险显著降低(26.3% vs 33.1%;RD -6.7%;95%CI -11.2至-2.3)。院内死亡方面,联合镇静低于丙泊酚为主组和右美托咪定为主组,但与丙泊酚组的差异在敏感性分析中不稳健,且28天和90天院内死亡不支持;与右美托咪定组的差异在各敏感性分析中一致。出院时功能下降各组无差异;联合镇静组气管切开更频繁,28天无呼吸机天数无差异。
要点
- 在细菌性肺炎机械通气成人ICU患者中,联合镇静较右美托咪定为主镇静与更低的复合结局风险相关(26.3% vs 33.1%;RD -6.7%;95%CI -11.2至-2.3)。
- 联合镇静与丙泊酚为主镇静相比,复合结局风险差异无统计学意义(26.3% vs 30.0%;RD -3.7%;95%CI -8.0至0.7)。
- 联合镇静组院内死亡率低于右美托咪定为主组(22.4% vs 30.1%;RD -7.7%;95%CI -12.1至-3.3),且敏感性分析一致。
- 联合镇静组气管切开更频繁,但28天无呼吸机天数与两对照组均无差异。
- 出院时功能下降在各镇静模式间无差异。
适用人群与场景
- 日本成人ICU中因细菌性肺炎需要机械通气的患者,数据来源于日本诊断程序组合数据库,纳入时间为2018年4月至2023年3月。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或目标值;仅将早期镇静实践模式分为联合镇静、丙泊酚为主镇静和右美托咪定为主镇静三组。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:全国性回顾性队列研究,使用日本诊断程序组合数据库,共纳入3302例成人ICU细菌性肺炎机械通气患者。
- 分组:联合镇静组1135例(34.4%),丙泊酚为主镇静组1067例(32.3%),右美托咪定为主镇静组1100例(33.3%)。
- 主要复合结局(院内死亡和出院时功能下降):联合镇静 vs 丙泊酚为主组 26.3% vs 30.0%,RD -3.7%(95%CI -8.0至0.7);联合镇静 vs 右美托咪定为主组 26.3% vs 33.1%,RD -6.7%(95%CI -11.2至-2.3)。
- 院内死亡:联合镇静 vs 丙泊酚为主组 22.4% vs 26.7%,RD -4.2%(95%CI -8.5至-0.03),但敏感性分析不稳健且28天和90天院内死亡不支持;联合镇静 vs 右美托咪定为主组 22.4% vs 30.1%,RD -7.7%(95%CI -12.1至-3.3),敏感性分析及28天、90天院内死亡一致。
- 出院时功能下降:各组间无差异。
- 气管切开:联合镇静组较两个对照组更频繁;28天无呼吸机天数:各组间无差异。
证据类型、等级与局限
- 证据类型:全国性回顾性队列研究,采用倾向评分匹配权重分析调整混杂因素。
- 局限:观察性设计可能存在未测量混杂;联合镇静与丙泊酚为主镇静的院内死亡差异在敏感性分析中不稳健,且28天和90天院内死亡不支持;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 在细菌性肺炎机械通气的成人ICU患者中,选择联合镇静而非右美托咪定单药镇静可能与更低的院内死亡和功能下降复合结局风险相关,但需注意联合镇静组气管切开更频繁。
- 与丙泊酚单药镇静相比,联合镇静未显示显著降低复合结局风险,且院内死亡差异不稳健,因此不能据此推荐联合镇静优于丙泊酚单药。
- 该研究为观察性设计,结果不能确立因果关系,临床决策需结合患者个体情况和最新指南。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although guidelines recommend light sedation with propofol or dexmedetomidine in mechanically ventilated patients, appropriate management with monotherapy is often challenging. Whether combined sedation reduces dose-dependent adverse effects of each agent or causes additive harm remains unclear. We investigated short-term outcomes associated with early sedation practice patterns in mechanically ventilated patients with bacterial pneumonia.
METHODS: Using the Japanese Diagnosis Procedure Combination database, we identified adult intensive care unit patients with bacterial pneumonia requiring mechanical ventilation between April 2018 and March 2023 and classified them into combined sedation, propofol-based sedation, and dexmedetomidine-based sedation groups. The composite outcome included in-hospital death and functional decline at discharge. Propensity-score matching-weight analyses adjusted for measured confounders.
RESULTS: Among 3,302 eligible patients, 1,135 (34.4%) were classified into the combined-sedation group, 1,067 (32.3%) into the propofol-based sedation group, and 1,100 (33.3%) into the dexmedetomidine-based sedation group. Combined sedation was not associated with a lower risk of the composite outcome compared with propofol-based sedation (26.3 % vs. 30.0 %; risk difference [RD] -3.7 %; 95% confidence interval [CI] -8.0 to 0.7) but was associated with a lower risk of the composite outcome compared with dexmedetomidine-based sedation (26.3 % vs. 33.1 %; RD -6.7%; 95% CI -11.2 to -2.3). In-hospital mortality was lower with combined sedation than propofol-based (22.4% vs. 26.7%; RD, -4.2%; 95% CI, -8.5 to -0.03) or dexmedetomidine-based (22.4% vs. 30.1%; RD, -7.7%; 95% CI, -12.1 to -3.3) sedation, although the comparison with propofol-based sedation was not robust in sensitivity analyses and was not supported by 28-day or 90-day in-hospital mortality. The in-hospital mortality difference between combined sedation and dexmedetomidine-based sedation was consistent across sensitivity analyses and 28-day and 90-day in-hospital mortality. Functional decline at discharge did not differ among groups. Tracheostomy was more frequent with combined sedation than with both comparators, whereas 28-day ventilator-free days did not differ.
CONCLUSIONS: Combined sedation was not associated with a lower risk of the composite outcome of in-hospital death and functional decline at discharge, compared with propofol-based sedation; however, a lower risk was observed compared with dexmedetomidine-based sedation.
参考来源
- Yajima W, Aso S, Matsui H, et al. Short-term outcomes across sedation practice patterns in mechanically ventilated patients with bacterial pneumonia: a nationwide cohort study. Ann Intensive Care. 2026. PMID: 42750884. doi:10.1016/j.aicoj.2026.100146
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。